Mitochondria-Associated Membranes Response to Nutrient Availability and Role in Metabolic Diseases

Trends in Endocrinology and Metabolism

Volumn 28, Issue 1, 2017, Pages 32-45

  Theurey, Pierre ^a   Rieusset, Jennifer ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

insulin resistance; metabolic flexibility; mitochondria associated membrane; organelle communication; protein phosphatase 2A

Indexed keywords

CALCIUM; GLUCOSE; INSULIN; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE 2;

BIOENERGY; CALCIUM HOMEOSTASIS; CELL METABOLISM; CELL ORGANELLE; HUMAN; METABOLIC DISORDER; METABOLIC REGULATION; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL MEMBRANE; NONHUMAN; NUTRIENT AVAILABILITY; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; ANIMAL; ENDOPLASMIC RETICULUM; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY;

ANIMALS; ENDOPLASMIC RETICULUM; HUMANS; INSULIN RESISTANCE; METABOLIC DISEASES; MITOCHONDRIAL MEMBRANES; PROTEIN PHOSPHATASE 2;

EID: 84995615128     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2016.09.002     Document Type: Review

References (101)

1. 1 Galgani, J.E., et al. Metabolic flexibility and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 295 (2008), E1009–E1017.
2. 2 Mandl, J., et al. Endoplasmic reticulum: nutrient sensor in physiology and pathology. Trends Endocrinol. Metab. 20 (2009), 194–201.
3. 3 Gao, A.W., et al. Mitochondrial response to nutrient availability and its role in metabolic disease. EMBO Mol. Med. 6 (2014), 580–589.
4. 4 Giorgi, C., et al. Mitochondria-associated membranes: composition, molecular mechanisms, and physiopathological implications. Antioxid. Redox Signal. 22 (2015), 995–1019.
5. 5 Theurey, P., et al. Mitochondria-associated endoplasmic reticulum membranes allow adaptation of mitochondrial metabolism to glucose availability in the liver. J. Mol. Cell Biol. 8 (2016), 129–143.
6. 6 Kelley, D.E., et al. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49 (2000), 677–683.
7. 7 Blaak, E.E., et al. Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes 49 (2000), 2102–2107.
8. 8 Blaak, E.E., et al. Beta-adrenergic stimulation of energy expenditure and forearm skeletal muscle metabolism in lean and obese men. Am. J. Physiol. 267 (1994), E306–E315.
9. 9 Kelley, D.E., et al. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 94 (1994), 2349–2356.
10. 10 Galgani, J.E., et al. Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate. Diabetes 57 (2008), 841–845.
11. 11 Morino, K., et al. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 55 (2006), S9–S15.
12. 12 Corpeleijn, E., et al. Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss. Obesity (Silver Spring) 16 (2008), 1025–1032.
13. 13 Oosterveer, M.H., et al. Hepatic glucose sensing and integrative pathways in the liver. Cell. Mol. Life Sci. 71 (2014), 1453–1467.
14. 14 Liesa, M., et al. Mitochondrial dynamics in mammalian health and disease. Physiol. Rev. 89 (2009), 799–845.
15. 15 Gomes, L.C., et al. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat. Cell Biol. 13 (2011), 589–598.
16. 16 Li, J., et al. Pharmacological activation of AMPK prevents Drp1-mediated mitochondrial fission and alleviates endoplasmic reticulum stress-associated endothelial dysfunction. J. Mol. Cell. Cardiol. 86 (2015), 62–74.
17. 17 Toyama, E.Q., et al. Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress. Science 351 (2016), 275–281.
18. 18 Frank, M., et al. Mitophagy is triggered by mild oxidative stress in a mitochondrial fission dependent manner. Biochim. Biophys. Acta 1823 (2012), 2297–2310.
19. 19 Bach, D., et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J. Biol. Chem. 278 (2003), 17190–17197.
20. 20 Mingrone, G., et al. Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity?. Diabetologia 48 (2005), 2108–2114.
21. 21 Ahn, B.H., et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 14447–14452.
22. 22 Jing, E., et al. Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation. Diabetes 62 (2013), 3404–3417.
23. + metabolism and SIRT1 activity. Nature 458 (2009), 1056–1060.
24. 24 Du, J., et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334 (2011), 806–809.
25. 25 Peng, C., et al. The first identification of lysine malonylation substrates and its regulatory enzyme. Mol. Cell. Proteomics, 10, 2011 M111.012658.
26. 26 Ploumi, C., et al. Mitochondrial biogenesis and clearance: a balancing act. FEBS J., 2016, 10.1111/febs.13820 Published online July 27, 2016.
27. 27 Canto, C., et al. AMP-activated protein kinase and its downstream transcriptional pathways. Cell. Mol. Life Sci. 67 (2010), 3407–3423.
28. 28 Egan, D.F., et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331 (2011), 456–461.
29. 29 Rodgers, J.T., et al. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434 (2005), 113–118.
30. 30 Canto, C., et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 11 (2010), 213–219.
31. 31 Gerhart-Hines, Z., et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J. 26 (2007), 1913–1923.
32. 32 Jeninga, E.H., et al. Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility. Oncogene 29 (2010), 4617–4624.
33. 33 Chomentowski, P., et al. Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility. J. Clin. Endocrinol. Metab. 96 (2011), 494–503.
34. 34 Schroder, M., Endoplasmic reticulum stress responses. Cell. Mol. Life Sci. 65 (2008), 862–894.
35. 35 Kaufman, R.J., et al. The unfolded protein response in nutrient sensing and differentiation. Nat. Rev. Mol. Cell Biol. 3 (2002), 411–421.
36. 36 Gonzales, J.C., et al. Chemical induction of the unfolded protein response in the liver increases glucose production and is activated during insulin-induced hypoglycaemia in rats. Diabetologia 51 (2008), 1920–1929.
37. 37 Elouil, H., et al. Acute nutrient regulation of the unfolded protein response and integrated stress response in cultured rat pancreatic islets. Diabetologia 50 (2007), 1442–1452.
38. 38 Cunha, D.A., et al. Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J. Cell Sci. 121 (2008), 2308–2318.
39. 39 Wikstrom, J.D., et al. AMPK regulates ER morphology and function in stressed pancreatic beta-cells via phosphorylation of DRP1. Mol. Endocrinol. 27 (2013), 1706–1723.
40. 2+ fluxes at the endoplasmic reticulum-mitochondria interface (MAM). Antioxid. Redox Signal. 16 (2012), 1077–1087.
41. 41 Verfaillie, T., et al. PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress. Cell Death Differ. 19 (2012), 1880–1891.
42. 42 Munoz, J.P., et al. Mfn2 modulates the UPR and mitochondrial function via repression of PERK. EMBO J. 32 (2013), 2348–2361.
43. 43 Bartlett, P.J., et al. Calcium-dependent regulation of glucose homeostasis in the liver. Cell Calcium 55 (2014), 306–316.
44. 44 Ozcan, L., et al. Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. Cell Metab. 15 (2012), 739–751.
45. 45 Wang, Y., et al. Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. Nature 485 (2012), 128–132.
46. 2+ release and apoptosis. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 2427–2432.
47. 47 Denton, R.M., Regulation of mitochondrial dehydrogenases by calcium ions. Biochim. Biophys. Acta 1787 (2009), 1309–1316.
48. 2+ activation of heart mitochondrial oxidative phosphorylation: role of the F(0)/F(1)-ATPase. Am. J. Physiol. Cell Physiol. 278 (2000), C423–C435.
49. 49 Eaton, S., Control of mitochondrial beta-oxidation flux. Prog. Lipid Res. 41 (2002), 197–239.
50. 2+ exchange, metabolic flexibility, and propensity for heart failure in mice. J. Clin. Invest. 120 (2010), 3680–3687.
51. 51 Sood, A., et al. A Mitofusin-2-dependent inactivating cleavage of Opa1 links changes in mitochondria cristae and ER contacts in the postprandial liver. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 16017–16022.
52. 52 Tubbs, E., et al. Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance. Diabetes 63 (2014), 3279–3294.
53. 2+ responses. Science 280 (1998), 1763–1766.
54. 54 Csordas, G., et al. Structural and functional features and significance of the physical linkage between ER and mitochondria. J. Cell Biol. 174 (2006), 915–921.
55. 2+ channels. J. Cell Biol. 175 (2006), 901–911.
56. 56 van Vliet, A.R., et al. New functions of mitochondria associated membranes in cellular signaling. Biochim. Biophys. Acta 1843 (2014), 2253–2262.
57. 57 Giorgi, C., et al. PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science 330 (2010), 1247–1251.
58. 58 Betz, C., et al. Feature article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), 12526–12534.
59. 2+-dependent apoptotic stimuli. Biochem. Biophys. Res. Commun. 375 (2008), 501–505.
60. 2+ signaling and apoptosis in a protein phosphatase-dependent manner. Cell Death Differ. 20 (2013), 1631–1643.
61. 2+ uptake disrupts insulin signaling in hypertrophic cardiomyocytes. Cell Commun. Signal., 12, 2014, 68.
62. 62 Kabashima, T., et al. Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc. Natl. Acad. Sci. U.S.A. 100 (2003), 5107–5112.
63. 63 Kowluru, A., et al. Hyperactivation of protein phosphatase 2A in models of glucolipotoxicity and diabetes: potential mechanisms and functional consequences. Biochem. Pharmacol. 84 (2012), 591–597.
64. 64 Hresko, R.C., et al. mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J. Biol. Chem. 280 (2005), 40406–40416.
65. 65 Pitts, K.R., et al. The dynamin-like protein DLP1 is essential for normal distribution and morphology of the endoplasmic reticulum and mitochondria in mammalian cells. Mol. Biol. Cell 10 (1999), 4403–4417.
66. 66 Slupe, A.M., et al. Determinants for substrate specificity of protein phosphatase 2A. Enzyme Res., 2011, 2011, 398751.
67. 67 Montgomery, M.K., et al. Mitochondrial dysfunction and insulin resistance: an update. Endocr. Connect. 4 (2015), R1–R15.
68. 68 Salvado, L., et al. Targeting endoplasmic reticulum stress in insulin resistance. Trends Endocrinol. Metab. 26 (2015), 438–448.
69. 69 Arruda, A.P., et al. Calcium homeostasis and organelle function in the pathogenesis of obesity and diabetes. Cell Metab. 22 (2015), 381–397.
70. 70 Lopez-Crisosto, C., et al. ER-to-mitochondria miscommunication and metabolic diseases. Cell Metab. 1852 (2015), 2096–2105.
71. 71 Lim, J.H., et al. Coupling mitochondrial dysfunction to endoplasmic reticulum stress response: a molecular mechanism leading to hepatic insulin resistance. Cell. Signal. 21 (2009), 169–177.
72. 72 Ozcan, L., et al. Activation of calcium/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signaling. Cell Metab. 18 (2013), 803–815.
73. 73 Fu, S., et al. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 473 (2011), 528–531.
74. 74 de Brito, O.M., et al. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 456 (2008), 605–610.
75. 75 Sebastian, D., et al. Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. Proc. Natl. Acad. Sci. U.S.A. 109 (2012), 5523–5528.
76. 76 Hagiwara, A., et al. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab. 15 (2012), 725–738.
77. 77 Ye, R., et al. Inositol 1,4,5-trisphosphate receptor 1 mutation perturbs glucose homeostasis and enhances susceptibility to diet-induced diabetes. J. Endocrinol. 210 (2011), 209–217.
78. 78 Paillard, M., et al. Depressing mitochondria-reticulum interactions protects cardiomyocytes from lethal hypoxia-reoxygenation injury. Circulation 128 (2013), 1555–1565.
79. 79 Rieusset, J., et al. Disruption of calcium transfer from ER to mitochondria links alterations of mitochondria-associated ER membrane integrity to hepatic insulin resistance. Diabetologia 59 (2016), 614–623.
80. 80 Schneeberger, M., et al. Mitofusin 2 in POMC neurons connects ER stress with leptin resistance and energy imbalance. Cell 155 (2013), 172–187.
81. 81 Chen, Y.F., et al. Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice. Genes Dev. 23 (2009), 1183–1194.
82. 2+ homeostasis. Hum. Mol. Genet. 23 (2014), 4770–4785.
83. 83 Arruda, A.P., et al. Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity. Nat. Med. 20 (2014), 1427–1435.
84. 84 Wong, P.M., et al. Regulation of autophagy by coordinated action of mTORC1 and protein phosphatase 2A. Nat. Commun., 6, 2015, 8048.
85. 85 Wu, Y., et al. Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase. J. Biol. Chem. 282 (2007), 9777–9788.
86. 86 Kowluru, A., et al. Ceramide-activated protein phosphatase-2A activity in insulin-secreting cells. FEBS Lett. 418 (1997), 179–182.
87. 87 Arora, D.K., et al. High glucose exposure promotes activation of protein phosphatase 2A in rodent islets and INS-1 832/13 beta-cells by increasing the posttranslational carboxylmethylation of its catalytic subunit. Endocrinology 155 (2014), 380–391.
88. 88 Galbo, T., et al. Free fatty acid-induced PP2A hyperactivity selectively impairs hepatic insulin action on glucose metabolism. PLoS ONE, 6, 2011, e27424.
89. 89 Nardi, F., et al. Enhanced insulin sensitivity associated with provision of mono and polyunsaturated fatty acids in skeletal muscle cells involves counter modulation of PP2A. PLoS ONE, 9, 2014, e92255.
90. 90 Zhang, X., et al. Quantitative proteomics reveals novel protein interaction partners of PP2A catalytic subunit in pancreatic beta-cells. Mol. Cell. Endocrinol. 424 (2016), 1–11.
91. 91 Lu, N., et al. Hepatocyte-specific ablation of PP2A catalytic subunit alpha attenuates liver fibrosis progression via TGF-beta1/Smad signaling. Biomed. Res. Int., 2015, 2015, 794862.
92. 92 Xian, L., et al. Liver-specific deletion of CPpp2calpha enhances glucose metabolism and insulin sensitivity. Aging (Albany NY) 7 (2015), 223–232.
93. 93 Cheng, Y.S., et al. PPP2R5C couples hepatic glucose and lipid homeostasis. PLoS Genet., 11, 2015, e1005561.
94. 94 Friedman, J.R., et al. ER tubules mark sites of mitochondrial division. Science 334 (2011), 358–362.
95. 95 Filadi, R., et al. Mitofusin 2 ablation increases endoplasmic reticulum-mitochondria coupling. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), E2174–E2181.
96. 96 Wieckowski, M.R., et al. Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nat. Protoc. 4 (2009), 1582–1590.
97. 97 Lewis, A., et al. Detection of isolated mitochondria-associated ER membranes using the Sigma-1 receptor. Methods Mol. Biol. 1376 (2016), 133–140.
98. 98 Vance, J.E., Phospholipid synthesis in a membrane fraction associated with mitochondria. J. Biol. Chem. 265 (1990), 7248–7256.
99. 2+ indicators based on computationally redesigned calmodulin-peptide pairs. Chem. Biol. 13 (2006), 521–530.
100. 2+ revealed by specifically targeted recombinant aequorin. Nature 358 (1992), 325–327.
101. 101 Csordas, G., et al. Imaging interorganelle contacts and local calcium dynamics at the ER-mitochondrial interface. Mol. Cell 39 (2010), 121–132.